Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets
Robert M. Cox, Josef D. Wolf, Richard K. Plemper
Topics & Concepts
Transmission (telecommunications)MedicineVirologyPandemicHerd immunityPopulationSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)ImmunologyPharmacologyInternal medicineDiseaseVaccinationEngineeringElectrical engineeringEnvironmental healthInfectious disease (medical specialty)SARS-CoV-2 and COVID-19 ResearchRespiratory viral infections researchInfluenza Virus Research Studies